Ketogenic diets that significantly lower glucose levels in vivo, when combined with the anti‐CTLA‐4 antibody, markedly retarded tumour progression by decreasing PD‐L1 expression and promoting antitumour immunity pathways.46 This evidence concerns the gene CD274 and neoplasm.